ROANOKE, VA – The non-profit CMR Institute, a leading education provider for biopharmaceutical and medical device professionals, has launched several and is planning to add more new e-courses, programs, and resources to help customers better understand a rapidly changing industry and succeed in the marketplace.
CMR Institute
How should companies prepare for new product introductions in an ACO environment?
By CMR Institute
Preparing for new product introductions in any environment is challenging, and ACOs are no different. The key is finding the right fit for a new product in an ACO, which requires understanding the challenges that ACOs face. Some of the key issues for ACOs include:
ACOs and Industry Conference to Be Held at the Millennium Hotel in Minneapolis on March 26-27, 2015
ROANOKE, VA – The non-profit CMR Institute, a leading education provider for biopharmaceutical and medical device professionals, will host its third annual conference focusing on effective collaboration between accountable care organizations (ACOs) and life sciences companies. ACOs and Industry: A Collaboration for Value will be held at the Millennium Hotel in Minneapolis on March 26–27, 2015.
Three things you need to know when selling to ACOs
By CMR Institute
Healthcare sales teams need to recognize that selling to ACOs requires a more educational approach, says Anthony Slonim, MD, DrPH, CPE, FACPE, President and CEO of Renown Healthand CMR Institute’s Board Chair.
In this one-minute video, Dr. Slonim explains the three things every sales professional should know when calling on ACOs.
What should you know before engaging in a #sales conversation with an #ACO decision maker?
By CMR Institute
Healthcare sales professionals need to develop a deep understanding of the issues affecting their ACO customersbefore they meet in person, says Jeff Farber, MD, CEO, Mount Sinai Care (ACO), and Chief Medical Officer, Mount Sinai Health Partners (MSO).
What is your strategy to sell above the physician?
By CMR Institute
When trying to find success with selling to the C-Suite, have you considered?
